MedReleaf Corp

Most Recent

  • uploads///cannabis _
    Company & Industry Overviews

    Revisiting Valuation Multiples for Cannabis Companies

    Recreational cannabis is close to being legalized in Canada, and producers are running at full bore to capture a piece of the market.

    By Adam Jones
  • uploads///EBITDA Margin FY  Estimates
    Company & Industry Overviews

    What Analysts Estimate for Cannabis Companies’ Earnings Margins

    Let’s now look at how capacity expansion could translate into cannabis companies’ margins.

    By Adam Jones
  • uploads///NAC Locations
    Company & Industry Overviews

    National Access Cannabis to Get Cannabis from CannaRoyalty

    Last week, National Access Cannabis signed a binding term sheet with CannaRoyalty (CRZ) to carry the latter’s products in its stores across Canada.

    By Adam Jones
  • uploads///Inventory Biological Assets
    Earnings Report

    How Canopy Growth Is Preparing for Legalized Cannabis

    During 3Q18, Canopy Growth increased its inventory and biological assets to a value of 108.3 Canadian dollars from 56 million Canadian dollars in 3Q17.

    By Adam Jones
  • uploads///marijuana _
    Miscellaneous

    MedReleaf Stock Rises on Aurora Cannabis Acquisition

    Today, Aurora Cannabis (ACB)(ACBFF) announced that it agreed to acquire all of MedReleaf’s (MEDFF) outstanding common shares for about 3.2 billion Canadian dollars.

    By Adam Jones
  • uploads///brown _
    Company & Industry Overviews

    Aurora Cannabis Stock Rises 5.8% on Investment in CTT

    On May 22, Aurora Cannabis acquired a 9.1% ownership interest in CTT Pharmaceutical Holdings through a private placement.

    By Adam Jones
  • uploads///Forward EV to Sales Multiple for Cannabis Sector
    Company & Industry Overviews

    How Cannabis Stocks’ Valuations Looked Last Week

    The forward EV-to-sales (enterprise value to sales) ratio for the cannabis sector hit a low point in April.

    By Adam Jones
  • uploads///Chart Title
    Miscellaneous

    How Aurora Cannabis and MedReleaf Stack Up in Cannabis Sector

    Cannabis companies are on an acquisition spree, and companies have made vertical and horizontal acquisitions within the industry.

    By Adam Jones
  • uploads///crown _
    Company & Industry Overviews

    Canopy Growth Rose 10% Yesterday: Why?

    Yesterday, April 30, Canopy Growth (WEED) rose 10% and closed the day at $30.10 Canadian.

    By Adam Jones
  • uploads///Brands
    Company & Industry Overviews

    Exploring Canopy Growth’s Acquisitions

    Canopy Growth (WEED) has been aggressively pursuing its expansion strategy to capture the recreational cannabis market in Canada.

    By Adam Jones
  • uploads///Aphria Analysts NTM Recommendation and Target
    Miscellaneous

    March Analyst Ratings and Price Targets for Aphria

    Aphria (APHQF) was among the worst performers this year with a loss of 34% YTD (year-to-date).

    By Adam Jones
  • uploads///Canopy Pipeline
    Miscellaneous

    Why GMP Securities Is Bullish on Canopy Growth

    Last week, GMP Securities analyst Martin Landry maintained a “buy” recommendation on the stock with a price target of 40 Canadian dollars.

    By Adam Jones
  • uploads///Canopy Growth Analysts NTM Recommendations and Targets
    Miscellaneous

    How Analysts View Canopy Growth

    As of March 22, the consensus analyst mean rating on Canopy Growth was 2.6, which remained unchanged from the previous month.

    By Adam Jones
  • uploads///Aphria Average Cost Per Gram
    Company & Industry Overviews

    Digging into Aphria’s Cost of Production

    In this part of the series, we’ll discuss how Aphria’s (APHQF) production costs have evolved in the last four quarters.

    By Adam Jones
  • uploads///weed _
    Company & Industry Overviews

    Comparing Major Cannabis Players’ Prices and Cost Structures

    Selling prices and per-gram production costs for cannabis will likely be defining factors in the success of Canadian cannabis producers.

    By Adam Jones
  • uploads///Revenue Estimate Revisions for
    Miscellaneous

    Analysts’ Revenue Estimate Revisions for Cannabis Stocks in March

    Cannabis producers’ (HMLSF) sales are expected to rise on expectations of their capturing the recreational cannabis market.

    By Adam Jones
  • uploads///CMED Acquisition
    Company & Industry Overviews

    Shoppers Drug Mart Makes Supply Deal with Aurora Cannabis

    Last week, Shoppers Drug Mart entered a supply agreement with Aurora Cannabis (ACB)(ACBFF) for medical cannabis.

    By Adam Jones
  • uploads///Filing Requirements
    Company & Industry Overviews

    What Cronos Group’s Listing on the NASDAQ Global Market Means

    With the elevation of its listing to the NASDAQ Global Market from the NASDAQ International Designation program, Cronos Group’s (PRMCF) management believes…

    By Adam Jones
  • uploads///mmj _
    Company & Industry Overviews

    Why Cannabis Stock Cronos Group Surged 11% Yesterday

    On February 26, cannabis company (HMMJ) Cronos Group (MJN)(PRMCF) surged almost 10.8%.

    By Adam Jones
  • uploads///Sunniva Stock Price Last Week
    Company & Industry Overviews

    What Happened in the Cannabis Sector Last Week

    Supply agreement with Sunniva With recreational cannabis set to become legal in Canada in mid-2018, Canopy Growth (WEED) continued to make developments to meet the anticipated demand with yet another announcement last week. On February 21, Canopy Growth signed a definitive agreement with Sunniva to purchase up to 90 tons of dried cannabis over two years. The […]

    By Adam Jones
  • uploads///weed _
    Company & Industry Overviews

    Why Cannabis Stock Canopy Growth Surged 12% Yesterday

    The Investment Industry Regulatory Organization of Canada imposed a trading halt on Canopy Growth at 4:11 PM EST on February 16, 2018.

    By Adam Jones
  • uploads///Top Holdings
    Company & Industry Overviews

    A Look at 2 New Marijuana ETFs that Debuted Last Week

    While marijuana stocks (MJX) ended in the negative territory week-over-week last week, two new marijuana sector-specific ETFs debuted.

    By Adam Jones
  • uploads///Gross Margins
    Earnings Report

    How Canopy Growth’s Margins Looked in 3Q18

    During 3Q18, Canopy Growth reported a non-GAAP (generally accepted accounting principles) gross margin of 58% of sales.

    By Adam Jones
  • uploads///Kilograms Harvested and Sold
    Earnings Report

    What Were Canopy Growth’s 3Q18 Sales Drivers?

    Sales volume, mix, and selling prices are key drivers for Canopy Growth’s (WEED) sales as well as for companies (HMLSF) such as Aphria (APHQF), Aurora Cannabis (ACBFF), and MedReleaf (MEDFF).

    By Adam Jones
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.